Sally Field Falls to 18% as Carey Mulligan Pulls Clear in Emmy Race

---

Sally Field's Emmy Chances Have Been Cut to 18%, Here's Why the Market Turned on Her

Sally Field is now trading at roughly 18% implied probability to win the 2026 Emmy for Outstanding Lead Actress in a Limited or Anthology Series or Movie, down from 29% three days ago, while frontrunner Carey Mulligan sits at 42%. Field's first Emmy nomination in 17 years, earned at age 79 for her role in Remarkably Bright Creatures, generated a wave of press attention when nominations were announced in July. That attention has not translated into betting confidence. The 12-point decline signals a market moving past the sentimental phase and into hard-nosed competitive analysis.

Prediction-market view

Resolved Sep 14, 2027

Final prices, venue by venue

This market settled on September 14, 2027, so nothing below is tradeable. These are the last prices each venue published before settlement, not live quotes.

Mulligan's 42% is more than double Field's current price. The gap between the two candidates is the story: Field dominated the post-nomination news cycle, but Mulligan dominated the repricing. No single confirmed catalyst from the past 72 hours explains the shift cleanly. This appears to be a market that priced in narrative excitement early and is now correcting toward competitive fundamentals as September 14 approaches.

The category also includes Sarah Snook (All Her Fault) at 22%, Sarah Pidgeon (Love Story: John F. Kennedy Jr. and Carolyn Bessette) at roughly 11%, and Claire Danes (The Beast in Me) at 4%, according to the full nominee list. Field is third in a five-nominee field, and the distance between her and the top two is growing.

---

Why Sally Field's First Emmy Nomination in 17 Years Looked Like a Genuine Contender Story

Field's opening price near 29% was not irrational. She is a two-time Emmy winner with decades of Television Academy goodwill. Her nomination for Remarkably Bright Creatures arrived with the kind of personal narrative that Emmy voters have historically rewarded: a legendary performer returning to the spotlight in a project that also earned nominations for Outstanding Movie and Outstanding Contemporary Costumes.

The Television Academy's voting membership skews older than the general audience. That demographic overlap works in Field's favor. Voters who watched Norma Rae, Places in the Heart, and Brothers and Sisters are more likely to feel the weight of a 79-year-old icon's return than younger viewers discovering her for the first time. Sentimental voting blocs have produced Emmy upsets before, and Field's story had the makings of exactly that kind of campaign.

The project itself carried credibility beyond its star. Remarkably Bright Creatures picked up additional recognition at the Gold Derby TV Awards and Gotham TV Awards, suggesting a broader coalition of industry support rather than a single-performance nomination carried entirely by name recognition.

---

Carey Mulligan vs. Sally Field: Why the Emmy Race Is Pulling Away

The math problem for Field is not that her case weakened. It is that Mulligan's case hardened. When one nominee consolidates above 40% in a five-person field, mathematical pressure compresses everyone else. Mulligan's 42% leaves only 58% of implied probability to be distributed among four other nominees, two of whom (Snook and Pidgeon) are absorbing meaningful shares themselves.

Mulligan brings prior Oscar nominations and deep awards-circuit credibility. Netflix's marketing infrastructure behind Beef Season 2 gives her campaign the kind of sustained voter-contact operation that independent films and streaming one-offs struggle to match. The platform gap matters in modern Emmy races, where "for your consideration" campaigns function like political ground games.

Field's contract touched a period low of 15% before recovering slightly, a bounce that may reflect opportunistic buying by traders who see value in the comeback narrative at a cheaper entry point. Kalshi shows her at 16% while Polymarket shows 19%, a modest spread that suggests both platforms are reading the competitive dynamics similarly.

---

The Case for Sally Field

Field's 18% is not a trivial number. It implies roughly a one-in-five chance, and several conditions could make the market wrong.

First, Emmy voting is not a prediction market. It is a private ballot cast by industry professionals who watch screeners at home, often in the final weeks before the ceremony. Late-breaking screener impressions can override months of campaign positioning. If Field's performance in Remarkably Bright Creatures is the kind of quiet, devastating work that hits harder on a second viewing, her odds improve as voting day nears.

Second, vote-splitting among the remaining nominees could create a path. If Mulligan and Snook divide the prestige drama vote while Pidgeon pulls younger voters, Field could win a fragmented plurality. This is the classic upset scenario in multi-nominee categories.

Third, the Television Academy has a documented tendency to reward legacy. Jessica Lange, Maggie Smith, and other established performers have won late-career Emmy awards in categories where younger competitors held momentum. Field fits that template precisely.

The counterweight is that none of these conditions are probable enough individually to override Mulligan's structural advantages. Campaign infrastructure, platform support, and critical momentum all point toward the frontrunner. Field's path to victory requires multiple things to break her way simultaneously, which is exactly what an 18% price reflects.

---

What to Watch Before September 14

The 78th Primetime Emmy Awards are scheduled for September 14 at the Peacock Theater in Los Angeles. Between now and then, two dynamics will determine whether Field's price stabilizes or declines further.

The first is the FYC screening calendar. If Remarkably Bright Creatures secures prominent placement in Television Academy screening events over the next three weeks, Field's odds could firm. If the film is buried beneath Netflix and HBO's higher-profile limited series campaigns, the current downtrend continues.

The second is whether any major industry endorsement or critical reassessment breaks in Field's direction. Without an external catalyst, the market's current trajectory points toward further consolidation around Mulligan.

For the latest pricing across all five nominees, check the full Emmy Lead Actress odds hub. The story of this category is not that Sally Field's comeback narrative failed. It is that narrative and probability are different currencies, and the market is now trading in the latter.